This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

CVS Health Gestione

Gestione criteri di controllo 3/4

CVS Health's CEO is Karen Lynch, appointed in Feb 2021, has a tenure of 3.5 years. total yearly compensation is $21.62M, comprised of 6.9% salary and 93.1% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth €26.20M. The average tenure of the management team and the board of directors is 2.4 years and 6.5 years respectively.

Informazioni chiave

Karen Lynch

Amministratore delegato

US$21.6m

Compenso totale

Percentuale dello stipendio del CEO	6.9%
Mandato del CEO	3.5yrs
Proprietà del CEO	0.04%
Durata media del management	2.4yrs
Durata media del Consiglio di amministrazione	6.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Karen Lynch rispetto agli utili di CVS Health?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	US$7b
Mar 31 2024	n/a	n/a	US$7b
Dec 31 2023	US$22m	US$2m	US$8b
Sep 30 2023	n/a	n/a	US$9b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$4b
Dec 31 2022	US$21m	US$1m	US$4b
Sep 30 2022	n/a	n/a	US$3b
Jun 30 2022	n/a	n/a	US$8b
Mar 31 2022	n/a	n/a	US$8b
Dec 31 2021	US$20m	US$1m	US$8b
Sep 30 2021	n/a	n/a	US$8b
Jun 30 2021	n/a	n/a	US$7b
Mar 31 2021	n/a	n/a	US$7b
Dec 31 2020	US$11m	US$1m	US$7b

Compensazione vs Mercato: Karen's total compensation ($USD21.62M) is above average for companies of similar size in the BG market ($USD4.41M).

Compensazione vs guadagni: Karen's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Karen Lynch (61 yo)

3.5yrs

Mandato

US$21,615,034

Compensazione

Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Karen Lynch	President	3.5yrs	US$21.62m	0.040% € 26.2m
Thomas Cowhey	Executive VP & CFO	less than a year	US$4.58m	0.0028% € 1.8m
Tilak Mandadi	Executive VP of Ventures and Chief Digital	2.1yrs	US$8.88m	0.0016% € 1.0m
Samrat Khichi	Executive VP	1.5yrs	US$11.89m	0.00078% € 507.1k
Prem Shah	Executive VP	2.8yrs	US$8.58m	0.0037% € 2.4m
Vijay Patel	Senior Director of Business Development & CVS Health and Partner & Co-Founder	no data	Nessun dato	Nessun dato
James Clark	Senior VP	5.8yrs	Nessun dato	0.00068% € 442.0k
Laurence McGrath	Senior Vice President of Business Development & Investor Relations	2.1yrs	Nessun dato	Nessun dato
David Falkowski	Executive VP & Chief Compliance Officer	no data	Nessun dato	Nessun dato
Laurie Havanec	Executive VP & Chief People Officer	3.5yrs	Nessun dato	0.0030% € 1.9m
J. Joyner	Executive Vice President & President of CVS Caremark	1.6yrs	Nessun dato	0.0032% € 2.1m
Michelle Peluso	Executive VP and Chief Customer & Experience Officer	3.6yrs	Nessun dato	0.0099% € 6.4m

2.4yrs

Durata media

59yo

Età media

Gestione esperta: CVS's management team is considered experienced (2.4 years average tenure).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Karen Lynch	President	3.5yrs	US$21.62m	0.040% € 26.2m
J. Kirby	Independent Director	less than a year	US$195.42k	0.00045% € 292.5k
Roger Farah	Independent Chairman	5.8yrs	US$576.50k	0.00033% € 214.5k
Mary Schapiro	Independent Director	7.3yrs	US$301.50k	0.00094% € 611.1k
Nancy-Ann DeParle	Independent Director	10.9yrs	US$321.50k	0.0025% € 1.7m
Anne Finucane	Independent Director	13.6yrs	US$321.50k	0.0026% € 1.7m
C. Brown	Independent Director	17.4yrs	US$321.50k	0.0097% € 6.3m
Jean-Pierre Millon	Independent Director	17.4yrs	US$321.50k	0.0088% € 5.7m
Alecia DeCoudreaux	Independent Director	9.4yrs	US$301.50k	0.00024% € 156.0k
Fernando Aguirre	Independent Director	5.8yrs	US$318.17k	0.0028% € 1.8m
Jeffrey Balser	Independent Director	1.9yrs	US$301.50k	0.00058% € 377.0k
Michael Mahoney	Independent Director	less than a year	US$167.50k	0.0011% € 702.1k

6.5yrs

Durata media

67.5yo

Età media

Consiglio di amministrazione esperto: CVS's board of directors are considered experienced (6.5 years average tenure).

This company listing is no longer active

CVS Health Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

CVS Health Corporation, Annual General Meeting, May 16, 2024

CVS Health Corporation, Annual General Meeting, May 16, 2024

Executive VP recently sold €2.1m worth of stock

CVS Health Announces Executive Changes

CVS Health Names Mark Santos as President, Aetna Medicaid

CVS Health Announces CFO Changes

Recent updates

Second quarter 2024 earnings released: EPS: US$1.41 (vs US$1.48 in 2Q 2023)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2024

CVS Health Corporation Launches First-Of-Its-Kind Initiative to Support Patients Most Vulnerable to Health Impacts of Extreme Weather Events

CVS Health Announces Quarterly Dividend, Payable on August 1, 2024

Investor sentiment deteriorates as stock falls 17%

The Law Firms of Kessler Topaz Meltzer & Check, LLP and Carella, Byrne, Cecchi, Brody & Agnello, P.C. Files a Class Action Lawsuit Against CVS Health Corporation and Related Entities for Preventing SilverScript Members from Accessing Certain Generic Medications

First quarter 2024 earnings released: EPS: US$0.88 (vs US$1.67 in 1Q 2023)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2024

CVS Health Corporation, Annual General Meeting, May 16, 2024

CVS Health Corporation, Annual General Meeting, May 16, 2024

CVS Health Corporation to Report Q1, 2024 Results on May 01, 2024

Cvs Health Approves Quarterly Dividend on the Common Stock, Payable on May 1, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Executive VP recently sold €2.1m worth of stock

Full year 2023 earnings released: EPS: US$6.49 (vs US$3.16 in FY 2022)

CVS Health Corporation Provides Earnings Guidance for the Year 2023

CVS Health Announces Executive Changes

Robbins Geller Rudman & Dowd LLP and Aqualaw PLC Reaches Settlements in Class Action with Costco Wholesale Corporation, CVS Health Corporation, The Procter & Gamble Company, Target Corporation, Walgreen Co. and Walmart Inc

CVS Health Approves Quarterly Dividend, Payable on February 1, 2024

CVS Health Names Mark Santos as President, Aetna Medicaid

Third quarter 2023 earnings released: EPS: US$1.76 (vs US$2.59 loss in 3Q 2022)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

CVS Health Announces CFO Changes

CVS Health Announces Executive Changes

CVS Health Approves Quarterly Dividend, Payable on November 1, 2023

CVS Health Corporation Updates Covid-19 Vaccine Now Available At CVS Pharmacy®

CVS Health Corporation Announces Additional Responsibilities for Executive Leadership Team Members

Senior VP recently sold €1.8m worth of stock

CVS Health Corporation to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: US$1.48 (vs US$2.31 in 2Q 2022)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

Court Denies CVS's Motion To Escape Discrimination Lawsuit Brought By HIV-Positive "John Doe" Plaintiffs

CVS Pharmacy Introduces New Universal Tools Collection from One+Other

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media